National Guideline Clearinghouse | Guidelines by Topic: Ovarian Neoplasms

National Guideline Clearinghouse | Guidelines by Topic: Ovarian Neoplasms

Guidelines by Topic

Disease/Condition > Diseases (2224) > Neoplasms (575) > Neoplasms by Site (427) > Endocrine Gland Neoplasms (59) >

Ovarian Neoplasms (29)

1-20 of 29   Next >
1. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. 1996 (revised 2014 Feb 18). NGC:010191 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
2. Management of epithelial ovarian cancer. A national clinical guideline. 2003 Oct (revised 2013 Nov). NGC:010080 Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
3. Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer. 2013 May. NGC:009893 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
4. Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer. 2013 May. NGC:009894 National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
5. Epithelial ovarian, fallopian tube, and primary peritoneal cancer. 2010 Jul (revised 2013 Apr). NGC:010253 CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
6. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.2007 Jun (revised 2013 Apr). NGC:009736 National Society of Genetic Counselors - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
7. Ovarian germ cell tumours. 2012 Apr (revised 2013 Apr). NGC:010263 CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
8. Cancer screening. 2004 May (revised 2012 Oct). NGC:009352 University of Michigan Health System - Academic Institution. View all guidelines by the developer(s) Compare Selected
9. Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. 1996 (revised 2012 Dec 18). NGC:009318 U.S. Preventive Services Task Force - Independent Expert Panel. View all guidelines by the developer(s) Compare Selected
10. ACR Appropriateness Criteria® clinically suspected adnexal mass. 1996 (revised 2012). NGC:009674 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
11. ACR Appropriateness Criteria® ovarian cancer screening. 1996 (revised 2012). NGC:009255 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
12. ACR Appropriateness Criteria® staging and follow-up of ovarian cancer. 1996 (revised 2012). NGC:009250 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
13. Early detection of cancers. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009647 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
14. Genetic counselling and testing. In: Guidelines for preventive activities in general practice, 8th edition.2012. NGC:009640 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
15. Screening tests of unproven benefit. In: Guidelines for preventive activities in general practice, 8th edition. 2012. NGC:009653 Royal Australian College of General Practitioners - Professional Association. View all guidelines by the developer(s) Compare Selected
16. Optimal chemotherapy for recurrent ovarian cancer. 2001 Sep 21 (revised 2011 Nov 21). NGC:009858 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
17. Management of suspected ovarian masses in premenopausal women. 2011 Nov. NGC:008987 British Society for Gynecological Endoscopy - Medical Specialty Society; Royal College of Obstetricians and Gynaecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
18. Management of a suspicious adnexal mass. 2011 Jul 7. NGC:008822 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
19. Ovarian cancer. The recognition and initial management of ovarian cancer. 2011 Apr. NGC:008756 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected
20. Risk reduction and surveillance strategies for individuals at high genetic risk for breast and ovarian cancer. 2011 Apr. NGC:009400 CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
1-20 of 29   Next > 21-29 of 29   < Previous 21. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. 1996 Feb (revised 2011). NGC:008496 Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected 22. The role of IMRT in gynecologic cancers. 2010 Oct 29. NGC:008827 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s) Compare Selected 23. Cancer screening. 2010 Feb. NGC:009537 Singapore Ministry of Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected 24. ACR practice guideline for the performance of magnetic resonance imaging (MRI) of the soft-tissue components of the pelvis. 2005 (revised 2010). NGC:008416 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected 25. ACR–ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources. 1996 (revised 2010). NGC:008422 American College of Radiology - Medical Specialty Society; American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s) Compare Selected 26. Noncontraceptive uses of hormonal contraceptives. 2010 Jan. NGC:007532 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s) Compare Selected 27. Elective and risk-reducing salpingo-oophorectomy. 1999 Sep (revised 2008 Jan; reaffirmed 2012). NGC:006287 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s) Compare Selected 28. Management of adnexal masses. 2007 Jul (reaffirmed 2011). NGC:006539 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by thedeveloper(s) Compare Selected 29. Contraception for women aged over 40 years. 2005 Jan (revised 2010 Jul). NGC:008191 Faculty of Sexual and Reproductive Healthcare - Professional Association. View all guidelines by the developer(s) Compare Selected 21-29 of 29   < Previous